277 related articles for article (PubMed ID: 23238456)
1. Moderate glucose control is associated with increased mortality compared with tight glucose control in critically ill patients without diabetes.
Lanspa MJ; Hirshberg EL; Phillips GD; Holmen J; Stoddard G; Orme J
Chest; 2013 May; 143(5):1226-1234. PubMed ID: 23238456
[TBL] [Abstract][Full Text] [Related]
2. Glycemic variability and mortality in critically ill patients: the impact of diabetes.
Krinsley JS
J Diabetes Sci Technol; 2009 Nov; 3(6):1292-301. PubMed ID: 20144383
[TBL] [Abstract][Full Text] [Related]
3. Effect of glycemic gap upon mortality in critically ill patients with diabetes.
Lou R; Jiang L; Zhu B
J Diabetes Investig; 2021 Dec; 12(12):2212-2220. PubMed ID: 34075715
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of Glycemic Gap to Predict ICU Mortality in Critically Ill Patients With Diabetes.
Liao WI; Wang JC; Chang WC; Hsu CW; Chu CM; Tsai SH
Medicine (Baltimore); 2015 Sep; 94(36):e1525. PubMed ID: 26356728
[TBL] [Abstract][Full Text] [Related]
5. Implementation of tight glucose control for critically ill surgical patients: a process improvement analysis.
Eachempati SR; Hydo LJ; Shou J; Barie PS
Surg Infect (Larchmt); 2009 Dec; 10(6):523-31. PubMed ID: 20001333
[TBL] [Abstract][Full Text] [Related]
6. Glycemic control in critically ill patients with or without diabetes.
Fong KM; Au SY; Ng GWY
BMC Anesthesiol; 2022 Jul; 22(1):227. PubMed ID: 35842591
[TBL] [Abstract][Full Text] [Related]
7. Time in blood glucose range 70 to 140 mg/dl >80% is strongly associated with increased survival in non-diabetic critically ill adults.
Krinsley JS; Preiser JC
Crit Care; 2015 Apr; 19(1):179. PubMed ID: 25927986
[TBL] [Abstract][Full Text] [Related]
8. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study.
Krinsley JS; Egi M; Kiss A; Devendra AN; Schuetz P; Maurer PM; Schultz MJ; van Hooijdonk RT; Kiyoshi M; Mackenzie IM; Annane D; Stow P; Nasraway SA; Holewinski S; Holzinger U; Preiser JC; Vincent JL; Bellomo R
Crit Care; 2013 Mar; 17(2):R37. PubMed ID: 23452622
[TBL] [Abstract][Full Text] [Related]
9. Software-guided insulin dosing: tight glycemic control and decreased glycemic derangements in critically ill patients.
Saur NM; Kongable GL; Holewinski S; O'Brien K; Nasraway SA
Mayo Clin Proc; 2013 Sep; 88(9):920-9. PubMed ID: 24001484
[TBL] [Abstract][Full Text] [Related]
10. Lower Glucose Target Is Associated With Improved 30-Day Mortality in Cardiac and Cardiothoracic Patients.
Hersh AM; Hirshberg EL; Wilson EL; Orme JF; Morris AH; Lanspa MJ
Chest; 2018 Nov; 154(5):1044-1051. PubMed ID: 29705217
[TBL] [Abstract][Full Text] [Related]
11. Blood glucose concentration and outcome of critical illness: the impact of diabetes.
Egi M; Bellomo R; Stachowski E; French CJ; Hart GK; Hegarty C; Bailey M
Crit Care Med; 2008 Aug; 36(8):2249-55. PubMed ID: 18664780
[TBL] [Abstract][Full Text] [Related]
12. Glucose control and mortality in critically ill patients.
Finney SJ; Zekveld C; Elia A; Evans TW
JAMA; 2003 Oct; 290(15):2041-7. PubMed ID: 14559958
[TBL] [Abstract][Full Text] [Related]
13. [The optimal blood glucose target in critically ill patient: comparison of two intensive insulin therapy protocols].
Raurell Torredà M; del Llano Serrano C; Almirall Solsona D; Catalan Ibars RM; Nicolás Arfelis JM
Med Clin (Barc); 2014 Mar; 142(5):192-9. PubMed ID: 23490488
[TBL] [Abstract][Full Text] [Related]
14. Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study.
Mesejo A; Montejo-González JC; Vaquerizo-Alonso C; Lobo-Tamer G; Zabarte-Martinez M; Herrero-Meseguer JI; Acosta-Escribano J; Blesa-Malpica A; Martinez-Lozano F
Crit Care; 2015 Nov; 19():390. PubMed ID: 26549276
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Basal Plus Versus Sliding Scale Insulin Therapy on Glucose Variability in Critically Ill Patients Without Preexisting Diabetes.
Webster RE; Belfer JJ; Schmidt KJ
Ann Pharmacother; 2024 Jun; 58(6):565-571. PubMed ID: 37700565
[TBL] [Abstract][Full Text] [Related]
16. Effect of published scientific evidence on glycemic control in adult intensive care units.
Niven DJ; Rubenfeld GD; Kramer AA; Stelfox HT
JAMA Intern Med; 2015 May; 175(5):801-9. PubMed ID: 25775163
[TBL] [Abstract][Full Text] [Related]
17. Percentage of Time in Range 70 to 139 mg/dL Is Associated With Reduced Mortality Among Critically Ill Patients Receiving IV Insulin Infusion.
Lanspa MJ; Krinsley JS; Hersh AM; Wilson EL; Holmen JR; Orme JF; Morris AH; Hirshberg EL
Chest; 2019 Nov; 156(5):878-886. PubMed ID: 31201784
[TBL] [Abstract][Full Text] [Related]
18. Coefficient of glucose variation is independently associated with mortality in critically ill patients receiving intravenous insulin.
Lanspa MJ; Dickerson J; Morris AH; Orme JF; Holmen J; Hirshberg EL
Crit Care; 2014 Apr; 18(2):R86. PubMed ID: 24886864
[TBL] [Abstract][Full Text] [Related]
19. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients.
Krinsley JS
Mayo Clin Proc; 2004 Aug; 79(8):992-1000. PubMed ID: 15301325
[TBL] [Abstract][Full Text] [Related]
20. Glucose control in the intensive care unit.
Fahy BG; Sheehy AM; Coursin DB
Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
